Casarejos M J, Menéndez J, Solano R M, Rodríguez-Navarro J A, García de Yébenes J, Mena M A
Department of Neurobiology, Hospital Ramon y Cajal, Madrid, Spain.
J Neurochem. 2006 May;97(4):934-46. doi: 10.1111/j.1471-4159.2006.03777.x. Epub 2006 Mar 29.
Parkinson's disease is a neurodegenerative disorder which is in most cases of unknown etiology. Mutations of the Park-2 gene are the most frequent cause of familial parkinsonism and parkin knockout (PK-KO) mice have abnormalities that resemble the clinical syndrome. We investigated the interaction of genetic and environmental factors, treating midbrain neuronal cultures from PK-KO and wild-type (WT) mice with rotenone (ROT). ROT (0.025-0.1 microm) produced a dose-dependent selective reduction of tyrosine hydroxylase-immunoreactive cells and of other neurons, as shown by the immunoreactivity to microtubule-associated protein 2 in PK-KO cultures, suggesting that the toxic effect of ROT involved dopamine and other types of neurons. Neuronal death was mainly apoptotic and suppressible by the caspase inhibitor t-butoxycarbonyl-Asp(OMe)-fluoromethyl ketone (Boc-D-FMK). PK-KO cultures were more susceptible to apoptosis induced by low doses of ROT than those from WT. ROT increased the proportion of astroglia and microglia more in PK-KO than in WT cultures. Indomethacin, a cyclo-oxygenase inhibitor, worsened the effects of ROT on tyrosine hydroxylase cells, apoptosis and astroglial (glial fibrillary acidic protein) cells. N-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase, increased ROT-induced apoptosis but did not change tyrosine hydroxylase-immunoreactive or glial fibrillary acidic protein area. Neither indomethacin nor N-nitro-L-arginine methyl ester had any effect on the reduction by ROT of the mitochondrial potential as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Microglial NADPH oxidase inhibition, however, protected against ROT. The roles of p38 MAPK and extracellular signal-regulated kinase signaling pathways were tested by treatment with SB20358 and PD98059, respectively. These compounds were inactive in ROT-naive cultures but PD98059 slightly increased cellular necrosis, as measured by lactate dehydrogenase levels, caused by ROT, without changing mitochondrial activity. SB20358 increased the mitochondrial failure and lactate dehydrogenase elevation induced by ROT. Minocycline, an inhibitor of microglia, prevented the dropout of tyrosine hydroxylase and apoptosis by ROT; the addition of microglia from PK-KO to WT neuronal cultures increased the sensitivity of dopaminergic neurons to ROT. PK-KO mice were more susceptible than WT to ROT and the combined effects of Park-2 suppression and ROT reproduced the cellular events observed in Parkinson's disease. These events were prevented by minocycline.
帕金森病是一种神经退行性疾病,在大多数情况下病因不明。Park-2基因的突变是家族性帕金森综合征最常见的病因,而帕金森基因敲除(PK-KO)小鼠具有类似于临床综合征的异常表现。我们研究了遗传和环境因素的相互作用,用鱼藤酮(ROT)处理PK-KO和野生型(WT)小鼠的中脑神经元培养物。ROT(0.025 - 0.1微摩尔)导致酪氨酸羟化酶免疫反应性细胞和其他神经元出现剂量依赖性的选择性减少,如PK-KO培养物中微管相关蛋白2的免疫反应性所示,这表明ROT的毒性作用涉及多巴胺能神经元和其他类型的神经元。神经元死亡主要是凋亡性的,可被半胱天冬酶抑制剂叔丁氧羰基 - 天冬氨酸(甲酯) - 氟甲基酮(Boc-D-FMK)抑制。与WT小鼠来源的培养物相比,PK-KO培养物对低剂量ROT诱导的凋亡更敏感。ROT在PK-KO培养物中比在WT培养物中更能增加星形胶质细胞和小胶质细胞的比例。环氧化酶抑制剂吲哚美辛会加重ROT对酪氨酸羟化酶细胞、凋亡和星形胶质细胞(胶质纤维酸性蛋白)的影响。一氧化氮合酶抑制剂N-硝基-L-精氨酸甲酯增加了ROT诱导的凋亡,但没有改变酪氨酸羟化酶免疫反应性或胶质纤维酸性蛋白区域。吲哚美辛和N-硝基-L-精氨酸甲酯对ROT导致的线粒体膜电位降低(通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐测量)均无影响。然而,抑制小胶质细胞NADPH氧化酶可预防ROT的损伤。分别用SB20358和PD98059处理来测试p38丝裂原活化蛋白激酶(MAPK)和细胞外信号调节激酶信号通路的作用。这些化合物在未接触ROT的培养物中无活性,但PD98059略微增加了由ROT引起的细胞坏死(通过乳酸脱氢酶水平测量),而不改变线粒体活性。SB20358增加了ROT诱导的线粒体功能衰竭和乳酸脱氢酶升高。小胶质细胞抑制剂米诺环素可预防ROT导致的酪氨酸羟化酶缺失和凋亡;将PK-KO小鼠的小胶质细胞添加到WT神经元培养物中会增加多巴胺能神经元对ROT的敏感性。PK-KO小鼠比WT小鼠对ROT更敏感,Park-2抑制和ROT的联合作用重现了帕金森病中观察到的细胞事件。这些事件可被米诺环素预防。